These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29188306)

  • 1. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.
    Becker JC; Stang A; Hausen AZ; Fischer N; DeCaprio JA; Tothill RW; Lyngaa R; Hansen UK; Ritter C; Nghiem P; Bichakjian CK; Ugurel S; Schrama D
    Cancer Immunol Immunother; 2018 Mar; 67(3):341-351. PubMed ID: 29188306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Merkel Cell Carcinoma.
    Harms PW
    Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
    Bhatia S; Afanasiev O; Nghiem P
    Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
    Akaike T; Nghiem P
    J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.
    Czapiewski P; Biernat W
    Int J Biochem Cell Biol; 2014 Aug; 53():536-46. PubMed ID: 24811434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates.
    Becker JC; Stang A; Schrama D; Ugurel S
    Am J Clin Dermatol; 2024 Jul; 25(4):541-557. PubMed ID: 38649621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
    Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
    Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathogenesis of Merkel Cell Carcinoma.
    DeCaprio JA
    Annu Rev Pathol; 2021 Jan; 16():69-91. PubMed ID: 33228463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Merkel cell polyomavirus among Swiss Merkel cell carcinoma patients.
    Mangana J; Dziunycz P; Kerl K; Dummer R; Cozzio A
    Dermatology; 2010; 221(2):184-8. PubMed ID: 20689250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on Merkel Cell Carcinoma.
    Emge DA; Cardones AR
    Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the biology and clinical management of Merkel cell carcinoma.
    Thakuria M; LeBoeuf NR; Rabinowits G
    Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.
    Stachyra K; Dudzisz-Śledź M; Bylina E; Szumera-Ciećkiewicz A; Spałek MJ; Bartnik E; Rutkowski P; Czarnecka AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
    Bichakjian CK; Olencki T; Aasi SZ; Alam M; Andersen JS; Blitzblau R; Bowen GM; Contreras CM; Daniels GA; Decker R; Farma JM; Fisher K; Gastman B; Ghosh K; Grekin RC; Grossman K; Ho AL; Lewis KD; Loss M; Lydiatt DD; Messina J; Nehal KS; Nghiem P; Puzanov I; Schmults CD; Shaha AR; Thomas V; Xu YG; Zic JA; Hoffmann KG; Engh AM
    J Natl Compr Canc Netw; 2018 Jun; 16(6):742-774. PubMed ID: 29891526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
    Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
    Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management.
    Rockville Merkel Cell Carcinoma Group
    J Clin Oncol; 2009 Aug; 27(24):4021-6. PubMed ID: 19597021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
    Amaral T; Leiter U; Garbe C
    Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
    Vandeven N; Nghiem P
    Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
    Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
    J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
    Amber K; McLeod MP; Nouri K
    Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.